Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors

por Strand, Vibeke, Reaney, Matthew, Chen, Chieh-I, Proudfoot, Clare W J, Guillonneau, Sophie, Bauer, Deborah, Mangan, Erin, Graham, Neil M H, van Hoogstraten, Hubert, Lin, Yong, Pacheco-Tena, César, Fleischmann, Roy
Publicado 2017

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis

por Strand, Vibeke, Gossec, Laure, Proudfoot, Clare W. J., Chen, Chieh-I, Reaney, Matthew, Guillonneau, Sophie, Kimura, Toshio, van Adelsberg, Janet, Lin, Yong, Mangan, Erin K., van Hoogstraten, Hubert, Burmester, Gerd R.
Publicado 2018